Related Experiment Video
Updated: Jun 26, 2026

System for Focal, Closed-System Central Nervous System Injury
Published on: November 29, 2024
Predictive factors and development of traumatic angle recession glaucoma following blunt ocular trauma
Hussin Izyani1,2, Hanafi Rahimie1,3, Pulanisamy Saranya4
1Department of Ophthalmology and Visual Sciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Abstract:
PurposeTo predict the development of traumatic angle recession glaucoma (TARG) and identify associated risk factors using Kaplan-Meier survival analysis.Materials and MethodsThis retrospective cohort study was conducted across three tertiary hospitals in Malaysia, involving patients treated for blunt ocular trauma and traumatic hyphaema between 1 January 2010 and 31 December 2020. Eligible patients had a minimum of one year of follow-up between 1 January and 31 December 2021. Data collected included demographics, medical and ocular history, injury mechanism, and initial ophthalmic assessment. Kaplan-Meier survival analysis and Cox proportional hazards regression were employed to evaluate glaucoma onset and prognostic indicators.ResultsOf 114 patients with angle recession, 30 (26.3%) developed TARG over a mean follow-up of 66.8 ± 52.1 months. Kaplan-Meier analysis estimated a mean survival time of 8.8 years, with most cases detected within nine months post-trauma. Age was a significant predictor, with a 1% increased risk per year (HR 1.02; 95% CI: 1.00-1.04; p = 0.022). Presence of peripheral anterior synechiae (PAS) conferred a 4.3-fold higher risk of developing TARG (HR 4.29; 95% CI: 2.02-9.13; p < 0.001).ConclusionOlder patients with PAS following blunt ocular trauma are at significantly increased risk for TARG and warrant close surveillance. Further research is needed to establish optimal follow-up duration and develop predictive tools for early identification of high-risk individuals.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
